News

It is my great honour to announce that Dr Birgit Poniatowski is the next Executive Director of IAS – the International AIDS Society. She assumes the role with immediate effect.

New results announced today by ViiV healthcare show that injection of long-acting pre-exposure prophylaxis (PrEP) cabotegravir every two months is 89% more effective than a daily Truvada oral pill (emtricitabine/tenofovir disoproxil fumarate) in a trial of women at increased risk of HIV acquisition.

Countering the COVID-19 infodemic requires not only facts, but also the coordinated and strategic advocacy for which those fighting HIV are renowned. Now more than ever, scientists need to counter lies and myths, and defend the integrity and independence of their enterprise. The emergence of the SARS-CoV-2 virus has not only led to the global COVID-19 pandemic, but also fueled an accompanying onslaught of misinformation. Some have promoted drugs such as hydroxychloroquine as cures for the disea...

Cori Vail has been elected as the ILF industry representative. Cori currently leads HIV Access Strategy & Impact efforts as part of Johnson & Johnson’s Global Public Health team. In this role, she is responsible for developing and executing insight-based strategies to accelerate adoption of transformational HIV innovation for underserved populations in resource-limited settings. Cori joined the Johnson & Johnson family of companies in 2003 and held numerous roles across engineering,...

It is with sadness and much gratitude that, on behalf of IAS - the International AIDS Society - Governing Council, I am letting you know that IAS Executive Director Kevin Osborne has announced his departure from the organization. After close to five successful years at the IAS, first as Director of HIV Programmes and Advocacy, and then as Executive Director, Kevin will depart at the end of September 2020 to join his partner abroad. With Kevin at the helm, the organization has benefited from his...

IAS has announced nine newly elected and three re-elected members to its Governing Council. Adeeba Kamarulzaman of Malaysia is the new IAS President and Sharon Lewin of Australia the President-Elect, with Jennifer Kates of the United States serving as Treasurer. “The new members joining the IAS Governing Council add a great diversity of skills and experiences,” IAS President Adeeba Kamarulzaman said. “They will be pivotal in steering IAS into the future and dealing with a fast-changing scien...

3 February 2020 (Geneva, Switzerland) - The Global HIV Vaccine Enterprise (the Enterprise), hosted by the International AIDS Society (IAS), shares the deep disappointment that the Phase 2b/3 HIV vaccine study HVTN 702 has been stopped by the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID).

Applications for the second round of the IAS Educational Fund Press Fellowship are now open. Taking place in Kigali, Rwanda, on 30 November – 4 December, the press fellowship aims to advance on-the-ground media coverage of the human and community impacts of implementing key HIV–related science and research. Applications will close on Sunday, 27 October, at 23:59 CET. Apply now The press fellowship offers selected journalists the opportunity to gain first-hand experience by visiting implement...

7 March 2019 (Geneva, Switzerland) – The International AIDS Society (IAS) today announced a new press fellowship series that aims to advance on-the-ground media coverage of the human and community impacts of implementing key HIV-related science and research. The IAS Educational Fund Press Fellowship offers selected journalists the opportunity to gain first-hand experience by visiting implementers of HIV programmes and their clients through exclusively tailored field trips. Additionally, they w...

5 March 2019 (Geneva, Switzerland) – The International AIDS Society (IAS) today welcomed an announcement that an HIV-positive man has remained in HIV remission off antiretroviral therapy (ART), 19 months after receiving a bone marrow transplant from a CCR5 negative donor for Hodgkin’s lymphoma. University College London (UCL) researchers made the announcement at the annual Conference on Retroviruses and Opportunistic Infections (CROI) being held in Seattle, USA, this week. Though there are...